Expression profile of Th1/Th2 transcription factors T-bet and GATA-3 in sarcoidosis, idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease Source: Annual Congress 2010 - Usefulness of bronchoalveolar lavage in diffuse parenchymal lung disease Year: 2010
Autoimmunity, T-cells and STAT-4 in the pathogenesis of chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 3-5 Year: 2004
The role of TREM-1 and TREM-2 receptors in immunopathogenesis of pulmonary sarcoidosis and hypersensitivity pneumonitis Source: Virtual Congress 2020 – Genetics and biomarkers for diagnosis and prognosis of granulomatous lung diseases Year: 2020
VEGF expression does not differentiate between idiopathic pulmonary fibrosis and pulmonary sarcoidosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007
The role of IL-10 receptors in aberrant homeostatic control of TNF-α in idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2002; 20: Suppl. 38, 599s Year: 2002
Role of Th17 cells in pulmonary sarcoidosis Source: Annual Congress 2010 - Sarcoidosis: genes and mechanisms Year: 2010
Relationship between MIF and cellular pattern in BAL of patients with sarcoidosis, systemic sclerosis, idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003
The effect of pentoxifylline on IL-12 and IL-18 release by alveolar macrophages in sarcoidosis and hypersensitivity pneumonitis versus idiopathic pulmonary fibrosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003
The role of chemokines and cytokines in lung fibrosis Source: Eur Respir Rev 2008; 17: 151-156 Year: 2008
COPD is associated with reduced pulmonary interstitial expression of pentraxin-3 Source: Eur Respir J 2012; 39: 830-838 Year: 2012
Cytokines in pathogenesis of pulmonary tuberculosis Source: Annual Congress 2011 - Tuberculosis: from bench to bedside Year: 2011
Can soluble CD-163 be related to disease activity in pulmonary sarcoidosis? Source: Annual Congress 2010 - Clinical issues in diffuse parenchymal lung disease Year: 2010
IL-36? – a key mediator of neutrophilic inflammation in chronic obstructive pulmonary disease Source: Virtual Congress 2021 – New insights into the airway immunology of lung disease Year: 2021
The clinical relevance of autoimmunity in idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012
Roles of TIMP-1 in the development of the pulmonary involvement in sarcoidosis Source: Eur Respir J 2004; 24: Suppl. 48, 551s Year: 2004
Interleukin-17 (IL-17) contributes to silica-induced alveolitis but is not essential in fibrosis development Source: Eur Respir J 2006; 28: Suppl. 50, 675s Year: 2006
Treg depletion reduces bleomycin-induced pulmonary fibrosis by inducing Th17 and other CD4+T cell subset responses in lung Source: International Congress 2016 – IPF: from pathogenesis to treatment II Year: 2016
STAT4 activation in smokers and patients with chronic obstructive pulmonary disease Source: Eur Respir J 2004; 24: 78-85 Year: 2004
Specific activation of non-classical Th1 cells in pulmonary sarcoidosis Source: International Congress 2015 – Sarcoidosis: pathogenesis Year: 2015
Role of cytokines in the immunopathogenesis of the MDR pulmonary tuberculosis Source: Annual Congress 2008 - Epidemiology and clinical management of multidrug-resistant and extensively drug-resistant tuberculosis Year: 2008